Home
Home » companies

Vivus

Vivus, Arena: Don't Be Too Late To The Punch Bowl, Buy Other Stocks

Vivus, Arena: Don't Be Too Late To The Punch Bowl, Buy Other Stocks
Seeking Alpha

Vivus' 60 Critical Minutes That Could Double Qsymia's Addressable Market

Vivus' 60 Critical Minutes That Could Double Qsymia's Addressable Market
Seeking Alpha

Arena And Vivus Set To Dominate The Obesity Drug Market

Arena And Vivus Set To Dominate The Obesity Drug Market
Seeking Alpha

3 Reasons to Sell: VIVUS

3 Reasons to Sell: VIVUS
Motley Fool

Now That Vivus Was Downgraded, Where Should Investors Turn?

Now That Vivus Was Downgraded, Where Should Investors Turn?
Seeking Alpha

3 Drug Companies That Want to Lose

3 Drug Companies That Want to Lose
Motley Fool

Healthcare Biz Recap: Vivus’ PATENT Problem, Idenix Survives Clinical HOLD

Healthcare Biz Recap: Vivus’ PATENT Problem, Idenix Survives Clinical HOLD
Wall Street Cheat Street

Vivus Falls after Downgrade

Vivus Falls after Downgrade
Barron's

Vivus Bulls: A Chance To Get In At $15.80 Or Earn An Extra 18.8%

Vivus Bulls: A Chance To Get In At $15.80 Or Earn An Extra 18.8%
Seeking Alpha

VIVUS tumbles after firm says doctors may replace company's drug with generics

VIVUS tumbles after firm says doctors may replace company's drug with generics
The Fly on the Wall